Noise during evening and nighttime hours tends to be associated with high annoyance, which is reflected in the use of community noise exposure metrics, such as the Ldn and Lden, that include penalties during these hours. Transportation noise sources may exhibit distinct diurnal patterns, but the impact of these patterns on different noise metrics has not been thoroughly evaluated, especially within the United States. In this study, we utilized General Transit Feed Specification (GTFS) data from 24 major cities in the U.S. to quantify diurnal traffic patterns for local buses, and the impact of these patterns on differences in noise metrics, such as LDay, LEvening, LNight, Ldn, and Lden, compared to the 24-hour LAeq24, Using mathematical conversions between the noise metrics, we found on average across the cities that the Ldn was between 2.8 to 3.6 dB higher than the LAeq24, and the Lden was also 3.6 to 3.8 dB higher than the LAeq24 for noise from local buses. This increase was mainly due to noise during daytime (LDay) that was higher than the 24-hour average noise, and dB penalties added to the Ldn and Lden metrics, which compensate for less bus traffic during evening and nighttime hours. We discuss the relevance of these conversions and the observed differences between the 24-hour LAeq24 and the Ldn and Lden, which are used for health impact assessments of high annoyance, on public transportation planning.

The authors have declared no competing interest.

This work was supported by the University of Washington EDGE Center of the National Institutes of Health [award number P30ES007033].

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors